Dr. Jamal Khan's Cancer Immunotherapy Makes a Mark
Dr. Jamal A. Khan is a pioneer in cancer immunotherapy in India, with over seven years of exclusive clinical experience in dendritic cell therapy. His work on dendritic cell therapy in treating cancer is unparalleled in India. Dr. Jamal A. Khan has been a researcher and teaching faculty at the Jawaharlal Nehru Medical College at Aligarh Muslim University, from 1997 till 2005.
- (1888PressRelease) April 26, 2016 - Given the challenges faced by millions of cancer patients, Delhi based Dr. Jamal Khan, MBBS MD; The Denvax Clinic provides a ray of hope for innumerable patients. A work pioneered by Dr. Khan in India over a decade and his efforts have been widely hailed today in a glittering ceremony at Delhi where he was decorated with innovators award organized by Optimal Media Solutions.
Acknowledging the award Dr. Khan expressed, "Our focus is to treat all the cancer patients through dendritic cell therapy and provide them a healthy life. I am overwhelmed to realize that my work and contribution gets remarked like this. I am glad to be a part of this event".
The ceremony also saw the unveiling of the coffee table book, 'Saluting the spirit of Entrepreneurship'. Guest of Honor present at the event was Shri Shyam Jaju, National Vice President, BJP. While addressing the audience, Shri Shyam Jaju said, "It is great to organize events like this and celebrate the success of people associated with different industries. And this book is the mark of the spirit shown by the established as well as emerging entrepreneurs".
Through the book, the event celebrated and saluted the spirit of the young unprecedented entrepreneurial brigade for accelerating and modernizing India's infrastructure in various critical areas like healthcare, education, retail, appliances, modern trade etc., through their vision and contributions.
The event witnessed a special performance by Films and Theatre Society through the play, 'Chakravyuh'. The play is inspired by the chapter from Mahabharata.
About Denvax:
DENVAX is dendritic cell based cancer immunotherapy. Dendritic cells (DC) therapy delays cancer progression and improves patient survival. At ICT, they have treated a number of cancer patients with M1 (metastatic) disease who are leading a recurrence-free quality life for many months to years. The Denvax Clinic has the experience in treating more than a thousand patients suffering from cancer in various stages of the disease.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam